Home Application Market Business Products Research Strategic Partnerships Investor Relations Contact
Mission Strategy Values

Strategy

Alterola Biotech’s strategy is to identify, acquire and develop the most innovative early stage research projects for medicine where chewing gum is already or could be a viable delivery method.

Alterola is diligently working on improving its functional chewing gum base so that it can be used for a wider array of purposes in addition to the common ones such as breath fresheners, nicotine gum, dental hygienic gum and caffeinated energy boosting gum. By continually researching new textures, flavors and active ingredients, Alterola will be able to create medicinal chewing gum for a number of other ailments. For an overview of current projects, please see the Products page.

Alterola Biotech thrive to work with a number of Contract Research Organizations in high-expertise but low cost countries. Alterola can purchase spare capacity with these CROs, always ensuring the lowest cost for the best possible research. Furthermore, this strategy gives Alterola Biotech much greater flexibility, a much trimmer balance sheet and an overall better ability to diverse and minimize its risk profile.

Alterola will adopt a strategy of early stage partnering with research institutions with unique intellectual properties, maturing the IP through its contract research institutions. Signing up IPs at an early stage will significantly lower the acquisition cost, as well as maximizing the expected revenue from these IPs.

The early stage acquisition strategy will be of great benefit both to the projects themselves, as well as to shareholders and other stakeholders.

"Alterola Biotech’s long term strategy is to identify, acquire and develop the most innovative early stage research projects for medicine where chewing gum is already or could be a viable delivery method"
[an error occurred while processing this directive]